|
|
A role for the complement system in seizure induced neuronal and dendritic injury |
| 5R01NS096234-02 |
BREWSTER, AMY L |
NIAID |
2020 |
|
|
A role for the complement system in seizure induced neuronal and dendritic injury |
| 5R01NS096234-02 |
BREWSTER, AMY L |
NIAID |
2020 |
|
|
Parental imprinting of the X chromosome: effects on neurodegeneration |
| 5R01NS096748-05 |
VOSKUHL, RHONDA R |
NIAID |
2020 |
|
|
Immune response to CNS injury |
| 5R01NS096967-05 |
KIPNIS, JONATHAN |
NIAID |
2020 |
|
|
SIV-induced Inflammation Causes Functional Impairment of the PNS |
| 5R01NS097221-05 |
MANKOWSKI, JOSEPH L |
NIAID |
2020 |
|
|
Targeting toll like receptor 4 (TLR4) and TLR2 to resolve EAE-associated paralysis, pain and cognitive deficits: efficacy of a clinically-relevant blood brain barrier permeable TLR4/TLR2 antagonist |
| 5R01NS097313-05 |
WATKINS, LINDA |
NIAID |
2020 |
|
|
Interactions Between Host Genetics and the Gut Microbiome in CNS Autoimmunity |
| 5R01NS097596-04 |
KREMENTSOV, DIMITRY N |
NIAID |
2020 |
|
|
Binding of Epstein Barr Virus EBNA2 unifies multiple sclerosis genetic mechanisms |
| 5R01NS099068-04 |
WEIRAUCH, MATTHEW TYSON |
NIAID |
2020 |
|
|
Examining the role of brain sodium content in multiplesclerosis using MRI |
| 5R01NS099527-04 |
LUBLIN, FRED D |
NIAID |
2020 |
|
|
Ursolic acid: a novel oral therapy for chronic stage of MS/EAE by both immunomodulation and neural repair |
| 5R01NS099594-04 |
ZHANG, GUANG-XIAN |
NIAID |
2020 |
